Cargando…

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoeflich, Andreas, Fitzner, Brit, Walz, Christina, Hecker, Michael, Tuchscherer, Armin, Bastian, Manuela, Brenmoehl, Julia, Schröder, Ina, Willenberg, Holger S., Reincke, Martin, Zettl, Uwe Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481359/ https://www.ncbi.nlm.nih.gov/pubmed/32982971 http://dx.doi.org/10.3389/fendo.2020.00574

Ejemplares similares

Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2021)

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
por: Abu-Mugheisib, Mazen, et al.
Publicado: (2011)

Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
por: Rommer, P. S., et al.
Publicado: (2014)

Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
por: Hellwig, Kerstin, et al.
Publicado: (2004)

Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis
por: Bühring, Jan, et al.
Publicado: (2021)

Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
por: Hecker, Michael, et al.
Publicado: (2021)

Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis
por: Hellwig, Kerstin, et al.
Publicado: (2006)

Triamcinolone acetonide acetate
por: Lu, Xiao, et al.
Publicado: (2011)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
por: Friess, Jörg, et al.
Publicado: (2017)

Microarray data of transcriptome shifts in blood cell subsets during S1P receptor modulator therapy
por: Koczan, Dirk, et al.
Publicado: (2018)

Partial phenotype conversion and differential trait response to conditions of husbandry in mice
por: Brenmoehl, Julia, et al.
Publicado: (2017)

Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes
por: Hecker, Michael, et al.
Publicado: (2021)

Browning of subcutaneous fat and higher surface temperature in response to phenotype selection for advanced endurance exercise performance in male DUhTP mice
por: Brenmoehl, J., et al.
Publicado: (2016)

Dynamics of Fat Mass in DUhTP Mice Selected for Running Performance – Fat Mobilization in a Walk
por: Brenmoehl, Julia, et al.
Publicado: (2015)

Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
por: Kahook, Malik Y, et al.
Publicado: (2009)

Patients treated with intravitreal triamcinolone acetonide
por: Gallenga, Pier E, et al.
Publicado: (2008)

Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing
por: Putscher, Elena, et al.
Publicado: (2022)

A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene
por: Hecker, Michael, et al.
Publicado: (2019)

Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress
por: Putscher, Elena, et al.
Publicado: (2021)

A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis
por: Kivitz, Alan, et al.
Publicado: (2019)

Uniform Suspension of the Clustered Triamcinolone Acetonide Particle
por: Sugimoto, Masahiko, et al.
Publicado: (2013)

Transdermal permeability of triamcinolone acetonide lipid nanoparticles
por: Qin, Zhenmiao, et al.
Publicado: (2019)

Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration
por: Formica, María Lina, et al.
Publicado: (2023)

Overlap of Peak Growth Activity and Peak IGF-1 to IGFBP Ratio: Delayed Increase of IGFBPs Versus IGF-1 in Serum as a Mechanism to Speed up and down Postnatal Weight Gain in Mice
por: Walz, Michael, et al.
Publicado: (2020)

Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide
por: Ansari, Ejaz A, et al.
Publicado: (2008)

Effects of triamcinolone acetonide on vessels of the posterior segment of the eye
por: Valamanesh, Fatemeh, et al.
Publicado: (2009)

Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
por: Pickrell, Aaron, et al.
Publicado: (2012)

Alopecia Areata—Successful Outcome with Microneedling and Triamcinolone Acetonide
por: Chandrashekar, BS, et al.
Publicado: (2014)

Lidocaine Potentiates the Deleterious Effects of Triamcinolone Acetonide on Tenocytes
por: Yang, Shu-long, et al.
Publicado: (2014)

Triamcinolone Acetonide-Assisted Descemetectomy for Retained Descemet Membrane
por: Tyring, Ariel, et al.
Publicado: (2018)

Anaphylaxis following intralesional triamcinolone acetonide (Kenacort) injection
por: Laisuan, Wannada, et al.
Publicado: (2017)

Successful treatment of acanthoma fissuratum with intralesional triamcinolone acetonide
por: Ramroop, Shivaughn
Publicado: (2020)

Extralesional triamcinolone acetonide injection in the treatment of small chalazion
por: Gan, Lu, et al.
Publicado: (2023)

Biochemical indicators for neuronal regeneration during intrathecal triamcinolone application in multiple sclerosis
por: Müller, Thomas, et al.
Publicado: (2015)

Implication of genetic variants in primary microRNA processing sites in the risk of multiple sclerosis
por: Hecker, Michael, et al.
Publicado: (2022)

Lifelong Obesity in a Polygenic Mouse Model Prevents Age- and Diet-Induced Glucose Intolerance– Obesity Is No Road to Late-Onset Diabetes in Mice
por: Renne, Ulla, et al.
Publicado: (2013)

Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide in Patients with Shoulder Osteoarthritis: An Open-Label, Randomized Study
por: Hanson, Peter, et al.
Publicado: (2021)

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Intralesional and sublesional injection of triamcinolone acetonide for oral lichen planus.
por: Sleeper, H. R.
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_thuptpdhn8euqtghgeeif9sbvc